MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tremors: Clinical features"

  • 2024 International Congress

    Profile of patients affected by movement disorders in subspecialized outpatient clinics of a tertiary hospital in Southern Brazil

    D. Teixeira-Dos-Santos, G. Magalhães Pereira, T. de Carvalho, P. Ribeiro Rigo, J. Käfer Pasin, I. Fonseca Benati, E. Drews Amorim, M. Testa-da-Silva, T. Lampert Monte, BS. de Oliveira, R. Machado Castilhos, AF. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: To delineate the epidemiological and clinical characteristics of movement disorders (MD) in patients attending subspecialty clinics at a tertiary hospital in Southern Brazil. Background:…
  • 2024 International Congress

    Jaw Clonus Masquerading as Jaw Tremor in a case of Amyotrophic Lateral Sclerosis (ALS)

    A. Boddu (Little Rock, USA)

    Objective: To highlight the importance of distinguishing jaw clonus from jaw tremor which can be a useful sign in clinical diagnosis by reporting a case…
  • 2024 International Congress

    Clinical characteristics of movement disorders associated with multiple sclerosis patients: A cross sectional preliminary single center results.

    MM. Meshref, AF. El-Adawy, FM. Mansour, MH. Moawad, MEL. Elmasry, HG. Gad (Cairo, Egypt)

    Objective: The aim of our study was to observe the clinical characteristics of different movement disorders (MD) in patients with multiple sclerosis (MS). Background: Demyelinating…
  • 2024 International Congress

    Application of Neurophysiology in the Clinical Evaluation of Pediatric and Adolescent Patients with Tremor

    B. Lavenstein, P. Mcgurrrin, F. Vial, E. Akano, S. Attaripour, P. Panyakaew, A. Choi, L. Pesantez-Pacheco, H. Lin, M. Hallett (Bethesda, USA)

    Objective: We explored the utility of noninvasive electrophysiological tremor studies in patients referred  for evaluation by pediatric movement specialists  following their clinical assessment . The…
  • 2024 International Congress

    Longitudinal Analysis of fragile X-associated tremor/ataxia syndrome Progression: A One-Year Follow-Up of 24 Patients

    M. Tosin, D. Hall, L. Quinchia (Chicago, USA)

    Objective: Determine the rate of progression of motor signs in fragile X-associated tremor/ataxia syndrome (FXTAS) over a one-year follow-up. Background: Limited information exists regarding the…
  • 2024 International Congress

    Levels of change in interleukin-6 levels according to clinical forms of Parkinson’s disease in patients with and without Covid-19

    B. Muminov, R. Matmurodov (Tashkent, Uzbekistan)

    Objective: Comparison of serum IL-6 levels in clinical forms Parkinson's disease (PD) patients with and without Сovid-19. Background: Changes in the treatment after infection with…
  • 2024 International Congress

    Evaluation of Functional Impairment and Treatment Satisfaction in Patients With Essential Tremor: a Cross-Sectional Study of Physicians Using Real-World Data

    T. Saifee, L. Barbato, J. Lin, A. Sillah, M. Baladi, S. Thomas, A. Gillespie, L. Harrison, S. Shah (London, United Kingdom)

    Objective: To describe the impact of tremor on activities of daily living (ADL) and treatment satisfaction in patients with essential tremor (ET). Background: ET, a…
  • 2024 International Congress

    Medication Effects on Bradykinesia and Tremor in Parkinson’s Disease, Measured by Wearable Sensors

    R. Weijer, A. Szanto, V. Exadaktylos, J. van Hilten, D. Hepp (Leiden, Netherlands)

    Objective: To determine the responsiveness to the effects of medication of home based unsupervised wearable sensor assessed tests for the evaluation of bradykinesia and tremor…
  • 2024 International Congress

    Tremulous Machado-Joseph Disease

    V. Procaci, L. de Farias, S. da Costa, O. Barsottini, J. Pedroso (Sao Paulo, Brazil)

    Objective: To describe a case of spinocerebellar ataxia type 3 (SCA3) presenting with tremor. Background: Tremor is not a frequent manifestation in SCA3, especially as…
  • 2024 International Congress

    Validation of a New Patient-reported Outcome Scale for the Assessment of Essential Tremor

    L. Shih, M. Stevenson, S. Bellows, A. Fasano, S. Kuo, K. Lyons, H. Moore, H. Shill, A. Shukla, C. Singer, R. Elble (Boston, USA)

    Objective: Develop and validate a TETRAS PRO subscale Background: The Essential Tremor Rating Assessment Scale (TETRAS) is a popular scale for essential tremor (ET), but…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley